Automated Partial Exchange Transfusion in Sickle Cell Anemia
- 10 September 1980
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 20 (5) , 578-584
- https://doi.org/10.1046/j.1537-2995.1980.20581034515.x
Abstract
Partial exchange transfusion is used to manage several of the complications of sickle cell anemia. Automated exchanges have been performed successfully in thirteen homozygous (SS) sickle cell patients and in one patient with hemoglobin SC. Although the expected acute increase in whole blood oxygen affinity occurred in each patient, there was no clinical evidence of detrimental effects during or immediately after each procedure, and in each case the patient was unchanged or improved when evaluated by exercise testing. By using a discontinuous-flow cell separator, it is possible to decrease the time required to achieve a 50 per cent exchange in an adult to approximately two hours. Transfusion of blood with an antigenic marker permits rapid evaluation of exchange efficiency during the procedure. When partial exchange transfusion is indicated, the discontinuous-flow cell separator provides a safe, rapid, and effective procedure.This publication has 19 references indexed in Scilit:
- Treatment of Sickle Cell DiseaseArchives of internal medicine (1960), 1977
- Exchange transfusion in sickle cell disease using a continuous‐flow blood cell separatorTransfusion, 1977
- Increasing Whole Blood Oxygen Affinity During Rapid Exchange Transfusion: a Potential HazardTransfusion, 1976
- Transfusion therapy for cerebrovascular abnormalities in sickle cell diseaseThe Journal of Pediatrics, 1976
- A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarctionAmerican Journal of Hematology, 1976
- Physiologic Effects of Transfusing Red Blood Cells With High or Low Affinity for Oxygen to Passively Hyperventilated, Anemic BaboonsAnnals of Surgery, 1975
- The treatment of sickle cell anemiaArchives of internal medicine (1960), 1974
- Extensive Bone Involvement in Sickle Cell Disease and Its TreatmentSouthern Medical Journal, 1971
- An Enzymatic Assay of 2,3 - Diphosphoglycerate in BloodScandinavian Journal of Clinical and Laboratory Investigation, 1969
- THERAPY OF CHRONIC ULCERATION OF THE LEGS ASSOCIATED WITH SICKLE CELL ANEMIAJAMA, 1954